BIBLIOGRAPHIC RECORD

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Elizabeth Berry‐Kravis; Randi Jenssen Hagerman; Dejan B. Budimirovic; Craig A. Erickson; Helen Heussler; Nicole R. Tartaglia; Jonathan Cohen; Flora Tassone; Thomas W Dobbins; Elizabeth P. Merikle; Terri B. Sebree; Nancy Tich; Joseph Palumbo; Stephen O’Quinn
Source of metadata
OpenAlex
Year recorded
2022

Public identifiers and source

Open the source record

Reference

Elizabeth Berry‐Kravis; Randi Jenssen Hagerman; Dejan B. Budimirovic; Craig A. Erickson; Helen Heussler; Nicole R. Tartaglia; Jonathan Cohen; Flora Tassone; Thomas W Dobbins; Elizabeth P. Merikle; Terri B. Sebree; Nancy Tich; Joseph Palumbo; Stephen O’Quinn. (2022). A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). https://openalex.org/W4310051511

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-af2f7cebd7d787f1a984cc676a69b98d/